Literature DB >> 20459703

Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years.

Belay Tessema1, Gizachew Yismaw, Afework Kassu, Anteneh Amsalu, Andargachew Mulu, Frank Emmrich, Ulrich Sack.   

Abstract

BACKGROUND: Transfusion-transmissible infectious agents such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis are among the greatest threats to blood safety for the recipient. This study aimed to determine the seroprevalence, risk factors and trends of HIV, HBV, HCV and syphilis infections among blood donors over a period of five years at Gondar University Teaching Hospital, Northwest Ethiopia.
METHODS: A retrospective analysis of consecutive blood donors' records covering the period between January 2003 and December 2007 was conducted. Logistic regression analysis was used to determine risk factors associated with HIV, HBV, HCV and syphilis infections.
RESULTS: From the total of 6361 consecutive blood donors, 607 (9.5%) had serological evidence of infection with at least one pathogen and 50 (0.8%) had multiple infections. The overall seroprevalence of HIV, HBV, HCV and syphilis was 3.8%, 4.7%, 0.7%, and 1.3% respectively. Among those with multiple infections, the most common combinations were HIV-syphilis 19 (38%) and HIV-HBV 17 (34%). The seropositivity of HIV was significantly increased among female blood donors, first time donors, housewives, merchants, soldiers, drivers and construction workers. Significantly increased HBV seropositivity was observed among farmers, first time donors and age groups of 26 - 35 and 36 - 45 years. Similarly, the seroprevalence of syphilis was significantly increased among daily labourers and construction workers. Statistically significant association was observed between syphilis and HIV infections, and HCV and HIV infections. Moreover, significantly declining trends of HIV, HCV and syphilis seropositivity were observed over the study period.
CONCLUSIONS: A substantial percentage of the blood donors harbour HIV, HBV, HCV and syphilis infections. Strict selection of blood donors and comprehensive screening of donors' blood using standard methods are highly recommended to ensure the safety of blood for recipient.

Entities:  

Mesh:

Year:  2010        PMID: 20459703      PMCID: PMC2881920          DOI: 10.1186/1471-2334-10-111

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

The discovery of transfusion-transmissible infections (TTIs) has heralded a new era in blood transfusion practice worldwide with emphasis on two fundamental objectives, safety and protection of human life [1]. Blood safety remains an issue of major concern in transfusion medicine in Ethiopia where national blood transfusion services and policies, appropriate infrastructure, trained personnel and financial resources are inadequate. Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are of great concern because of their prolonged viraemia and carrier or latent state. They also cause fatal, chronic and life-threatening disorders. Blood transfusion accounts for 5-10% of HIV infections in sub-Saharan Africa [2]. Similarly, 12.5% of patients who received blood transfusion are at risk of posttransfusion hepatitis [3]. HBV is highly contagious and relatively easy to be transmitted from one infected individual to another by blood transfusion, during birth, by unprotected sex, and by sharing needles and has a relatively higher prevalence in the tropics [4,5]. A study conducted in Addis Ababa, Ethiopia showed that HCV antibody prevalence was 0.9% and higher among HIV-positive compared to HIV-negative individuals (4.5% vs. 0.8%, respectively). Similarly, higher prevalence of HCV antibodies was seen among HIV-positive compared to HIV negative antenatal care attenders (2.9% vs. 0.8%, respectively), and sex workers (5.3% vs. 1.3%, respectively) [6]. Syphilis is also a systemic disease caused by Treponema pallidum which can be spread by sexual contact, blood transfusion and via vertical transmission [7]. In sub-Saharan Africa, syphilis remains a serious public health problem. Prevalence of active syphilis infection among African countries showed 12.8% in Tanzania [8], and 3.8% in Kenya [9]. A study conducted to assess the prevalence of infection with HIV, syphilis and HBV among Ethiopian blood donors in 1995 showed that the seroprevalence of HIV-1, syphilis and HBV was 16.7%, 12.8% and 14.4%, respectively [10]. The high prevalence of HIV, HBV, HCV and syphilis has heightened the problems of blood safety in Ethiopia. Thus, continuous monitoring of the magnitude of transfusion-transmissible infections in blood donors is important for estimating the risk of transfusion and optimizing donor recruitment strategies to minimize infectious diseases transmission. Therefore, this study was conducted to determine the seroprevalence, risk factors and trends of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital in Northwest Ethiopia.

Methods

Study design, setting and study subjects

A retrospective analysis of consecutive blood donors' records covering the period between January 2003 and December 2007 was conducted at Gondar University Teaching Hospital. The hospital is a tertiary level teaching hospital that provides health service to over five million inhabitants in Northwest Ethiopia, and is located 727 Km north from the capital city, Addis Ababa. Institutional ethical clearance was obtained from the research and publication committee of Gondar University. However, due to the nature of the study (retrospective review of blood donors' records), informed consent was not obtained from the study subjects. Blood donors were either volunteers, or relatives or friends of patients and commercial donors who were recruited and paid by patients, their families, or friends to replace blood used or expected to be used for patients from the blood bank of the hospital. In the blood bank unit of the hospital, the first step in screening for potential blood donors is taking past medical history of the client. Individuals are required to give answers to a panel of questions on previous illnesses and medical conditions. Past history of blood transfusion and questions targeted to ascertain risky sexual behavior and practice are also part of the questionnaire. Apparently healthy subjects of age 17 to 65 years with body weight above 45 kg would qualify for donation. The medical and socio-demographic histories of the donors were recorded in the logbook and venous blood was collected in blood banking bags following standard procedures.

Laboratory diagnosis for HIV 1 and 2

Each donor's serum sample was screened for HIV-1 and HIV-2 using Vironostika HIV Uni-Form II Ag/Ab (BioMerieux, Boxtel, The Netherlands) following the manufacturer's instructions.

Laboratory tests for HBsAg and HCV antibodies

Sera were checked for the presence of hepatitis B surface antigen (HBsAg) using ELISA, Hepanostika HBsAg (Murex Biotech Ltd, Dartford, UK). Similarly, IgG antibodies to HCV were detected using an ELISA technique (Murex anti-HCV version 4.0) according to the manufacturer's instructions.

Laboratory diagnosis for syphilis

Serum from all donors was tested for the presence of treponemal antibodies using rapid plasma reagin test (RPR) following the manufacturer's instructions (RPR, Wampole Laboratories, Princeton, N.J., USA).

ABO blood grouping and Rhesus (RH) typing

ABO and Rh blood groups determinations were carried out on a slide using monoclonal blood grouping antisera; anti-A, anti-B, anti-AB, and anti-D (BIOTEC Laboratories Ltd, Great Britain).

Statistical analysis

Data were entered, cleaned and analysed using SPSS version 13 statistical package. To ensure the quality of data entered into the computer, two people independently cross-checked each entry. Differences in prevalence of HIV, HBV, HCV and syphilis for Socio-demographic variables were tested for significance using logistic regression. Moreover, linear regression was used to assess the statistical significance of trends in seroprevalence of these pathogens over the study period. P value less than 0.05 was considered statistically significant.

Results

Demographic characteristics of donors

As shown in Table 1, a total of 6361 consecutive blood donors were screened at Gondar University Teaching Hospital blood bank unit during the study period. Of these, 5592 (87.9%) donors were males and 769 (12.1%) were females. The median age of the study subjects was 25 years (range 17 - 65 years). Of all donors, 3357 (52.8%) were in the age group of 17-25 years, 4372 (68.7%) were first time donors, 2952 (46.4%) were blood group O and 5984 (94.1%) were Rhesus D (RH) positive. In addition, daily labourers (27.8%), farmers (24.8%) and students, more frequently Collage/University students (21.2%) were constitute a major chunk of the blood donors. The relatively higher number of farmer and daily labourer donors may be due to the fact that farmers constitute a major portion of the general population and majority of the commercial blood donors are daily labourers.
Table 1

Socio—demographic characteristics of blood donors at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007

CharacteristicsNumber (%)
Age group (years)
 17 – 253357 (52.8)
 26 – 351686 (26.5)
 36 – 45757 (11.9)
 46 – 55395 (6.2)
 56 – 65166 (2.6)
Gender
 Male5592 (87.9)
 Female769 (12.1)
Occupation
 Daily labourer1769 (27.8)
 Farmer1575 (24.8)
 Student1347 (21.2)
 Housewife212 (3.3)
 Govt. employee599 (9.4)
 Merchant333 (5.2)
 Soldier47 (0.7)
 Driver120 (1.9)
 Construction worker343 (5.4)
 Others16 (0.3)
Number of donation
 First donation4372 (68.7)
 Repeat donation1989 (31.3)
ABO Blood groups
 O2952 (46.4)
 A1715 (27.0)
 B1406 (22.1)
 AB288 (4.5)
Rhesus (RH) type
 Positive5984 (94.1)
 Negative377 (5.9)
Socio—demographic characteristics of blood donors at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007

Seroprevalence of HIV, HBV, HCV and syphilis

The overall seroprevalence rate of HIV, HBV, HCV and syphilis was 3.8%, 4.7%, 0.7% and 1.3% respectively (Table 2). Of all donated blood during the study period, 607 (9.5%) had serological evidence of infection with at least one pathogen and 50 (0.8%) had multiple infections. Among those with multiple infections, the most common combinations were HIV- syphilis 19 (38%) and HIV - HBV 17 (34%) (Table 3). As shown in Table 4, the seroprevalence of HIV was significantly increased among female blood donors (P < 0.001) compared to male blood donors, first time donors (P < 0.001) compared to repeat donors, and among housewives (P < 0.001), merchants (P < 0.001), soldiers (P = 0.020), drivers (P = 0.041) and construction workers (P = 0.009) compared to students. The seroprevalence of syphilis was significantly increased among daily labourers (P = 0.001) and construction workers (P = 0.013) compared to students. Similarly, the seropositivity of HBV was significantly increased among donors with the age groups of 26 - 35 and 36 - 45 years compared to the age group greater than 45 years, farmers (P = 0.005) compared to students and first time donors (P < 0.001) compared to repeat donors (Table 5).
Table 2

Trends of seropositivity of HIV, Syphilis, HBV and HCV among blood donors at Gondar University Teaching Hospital in Northwest Ethiopia 2003 - 2007

YearTotal screenedNHIV positiveN (%)Syphilis positiveN (%)HBV positiveN (%)HCV positiveN (%)
2003115658 (5.0)45 (3.9)62 (5.4)X
2004169361 (3.6)33 (1.9)85 (5.0)23 (1.4)
2005118747 (4.0)1 (0.1)63 (5.3)7 (0.6)
2006104533 (3.2)2 (0.2)30 (2.9)3 (0.3)
2007128040 (3.1)2 (0.2)58 (4.5)2 (0.2)
Total6361239 (3.8)83 (1.3)298 (4.7)35 (0.7)
p-Value of linear regression for trend_0.021<0.0010.061<0.001

N = Number; X = Not done

Table 3

Prevalence of co-infections of HIV, HBV, HCV and syphilis among blood donors at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007

Co-infectionsNumberPercent
HIV - Syphilis1938.0
HIV - HBV1734.0
HIV - HCV48.0
HBV - Syphilis714.0
HBV - HCV24.0
Syphilis - HCV12.0
Total50100
Table 4

Socio–demographic characteristics of blood donors by HIV and Syphilis sero positivity at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007

CharacteristicsHIV PositiveN (%)OR (95% CI)P-ValuesSyphilis PositiveN (%)OR (95% CI)P-Values
Age group (years)
 17 – 25105/3357 (3.1)1.03 (0.61 - 1.74)0.90231/3357 (0.9)0.64 (0.30 - 1.41)0.271
 26 – 3579/1686 (4.7)1.57 (0.92 - 2.68)0.09628/1686 (1.7)1.17 (0.53 - 2.58)0.702
 36 – 4538/757 (5.0)1.69 (0.94 - 3.03)0.07716/757 (2.1)1.49 (0.63 - 3.51)0.359
 > 4517/561 (3.0)1.00-8/561 (1.4)1.00-
Gender
 Male188/5592 (3.4)1.00-76/5592 (1.4)1.00-
 Female51/769 (6.6)2.04 (1.48 - 2.81)<0.0017/769 (0.9)0.67 (0.31 - 1.45)0.307
Occupation
 Student34/1347 (2.5)1.00_9/1347 (0.7)1.00_
 Daily labourer53/1769 (3.0)1.19 (0.77 - 1.85)0.42938/1769 (2.1)3.26 (1.57 - 6.77)0.001
 Farmer56/1575 (3.6)1.42 (0.92 - 2.19)0.10920/1575 (1.3)1.91 (0.87- 4.21)0.108
 Housewife26/212 (12.3)5.40 (3.17 - 9.20)<0.0013/212 (1.4)2.13 (0.57 - 7.95)0.258
 Govt.employee17/599 (2.8)1.13 (0.63 - 2.04)0.6890/599--
 Merchant23/333 (6.9)2.87 (1.66 - 4.93)<0.0014/333 (1.2)1.81 (0.55-5.91)0.327
 Military4/47 (8.5)3.59 (1.22 -10.57)0.0200/47--
 Driver7/120 (5.8)2.39 (1.04 - 5.52)0.0411/120 (0.8)1.25 (0.16 - 9.95)0.833
 Construction worker19/359 (5.3)2.16 (1.22 - 3.83)0.0098/359 (2.2)3.39 (1.30 - 8.85)0.013
Number of donation
 First donation212/4372 (4.8)3.70 (2.47 - 5.55)<0.00156/4372 (1.3)0.94 (0.59 - 1.50)0.803
 Repeat donation27/1989 (1.4)1.00-27/1989 (1.4)1.00-
HIV status
 Positive---19/239 (7.9)8.18 (4.81- 13.88)<0.001
 Negative---64/6122 (1.0)1.00-

OR = Odds ratio; CI = Confidence interval; N = Negative

Table 5

Socio–demographic characteristics of blood donors by hepatitis B and C virus seropositivity at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007

CharacteristicsHBV PositiveN (%)OR (95% CI)P-ValuesHCV Positive N (%)OR (95% CI)P-Values
Age group (years)
 17 - 25144/3357 (4.3)1.43 (0.86 - 2.39)0.16616/2726 (0.6)0.91 (0.26 - 3.12)0.875
 26 - 3589/1686 (5.3)1.78 (1.05 - 3.02)0.03213/1395 (0.9)1.44 (0.41 - 5.08)0.569
 36 - 4548/757 (6.3)2.17 (1.23 - 3.810.0073/621 (0.5)0.74 (0.15 - 3.71)0.718
 > 4517/561 (3.0)1.00-3/463 (0.6)1.00-
Gender
 Male273/5592 (4.9)1.00-34/4528 (0.8)1.00-
 Female25/769 (3.3)0.66 (0.43 - 0.99)0.0461/677 (0.1)0.20 (0.03 - 1.43)0.108
Occupation
 Student55/1347 (4.1)1.00_6/1188 (0.5)1.00_
 Daily labourer79/1769 (4.5)1.10 (0.77 - 1.56)0.6028/1312 (0.6)1.21 (0.42 - 3.49)0.726
 Farmer102/1575 (6.5)1.63 (1.16 - 2.28)0.00514/1293 (1.1)2.16 (0.83 - 5.63)0.117
 Housewife7/212 (3.3)0.80 (0.36 - 1.79)0.5891/179 (0.6)1.11 (0.13 - 9.25)0.925
 Govt.employee20/599 (3.3)0.81 (0.48 - 1.37)0.4322/525 (0.4)0.75 (0.15 - 3.75)0.729
 Merchant12/333 (3.6)0.88 (0.47 - 1.66)0.6890/288--
 Military2/47 (4.3)1.04 (0.25 - 4.42)0.9530/34--
 Driver4/120 (3.3)0.81 (0.29 - 2.28)0.6890/103--
 Construction worker17/359 (4.7)1.17 (0.67 - 2.04)0.5854/283 (1.4)2.82 (0.79 - 10.08)0.110
Number of donation
 First donation231/4372 (5.3)1.60 (1.21 - 2.11)<0.00125/3610 (0.7)1.11 (0.53 - 2.31)0.79
 Repeat donation67/1989 (3.4)1.00-10/1595 (0.6)1.00-
HIV status
 Positive17/239 (7.1)1.59 (0.96 - 2.64)0.074/181 (2.2)3.64 (1.27- 10.42)0.02
 Negative281/6122 (4.6)1.00-31/5024 (0.6)1.00-

OR = Odds ratio; CI = Confidence interval; N = Negative

Trends of seropositivity of HIV, Syphilis, HBV and HCV among blood donors at Gondar University Teaching Hospital in Northwest Ethiopia 2003 - 2007 N = Number; X = Not done Prevalence of co-infections of HIV, HBV, HCV and syphilis among blood donors at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007 Socio–demographic characteristics of blood donors by HIV and Syphilis sero positivity at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007 OR = Odds ratio; CI = Confidence interval; N = Negative Socio–demographic characteristics of blood donors by hepatitis B and C virus seropositivity at Gondar University Teaching Hospital in Northwest Ethiopia 2003-2007 OR = Odds ratio; CI = Confidence interval; N = Negative The prevalence rate of syphilis, HBV and HCV among HIV infected donors was 7.9%, 7.1%, and 2.2% respectively, compared with the prevalence rate of 1.0%, 4.6% and 0.6% among HIV-seronegative donors. Furthermore, statistically significant association was observed between syphilis and HIV infection (P < 0.001) (Table 4), and HCV and HIV infection (P = 0.002) (Table 5).

Trends of HIV, HBV, HCV and syphilis seroprevalence

Significantly declining trends of HIV (P = 0.021), HCV (P < 0.001) and syphilis (P < 0.001) seroprevalence were observed over the five years study period. The seroprevalence of HIV was 5.0% in 2003 and decreased to 3.6% in 2004 and slightly increased to 4.0% in 2005 but subsequently decreased to 3.2% in 2006 and 3.1% in 2007. The seroprevalence of HBV was decreased from 5.4% in 2003 to 2.9% in 2006 and increased further to 4.5% in 2007. HCV prevalence decreased steadily from 1.4% in 2004 to 0.6% in 2005, 0.3% in 2006, and 0.2% in 2007. Similarly, the prevalence of syphilis decreased progressively from 3.9% in 2003 to 1.9% in 2004, 0.1% in 2005 and 0.2% in 2006 and 2007 (Table 2).

Discussion

In this study, significantly declining trends of HIV, HCV and syphilis seroprevalence were observed among blood donors over the study period. This finding is consistent with the observed declining trend of HIV seroprevalence in the general population in Ethiopia [11], declining trend of HIV prevalence among blood donors in Ethiopia [12], declining trend of HIV prevalence among pregnant women, and declining trend of syphilis infections among pregnant women in Addis Ababa [13]. The initial rise in HIV seroprevalence among the blood donors represents the peak of the epidemic when denial was prevalent and little attention was paid to the disease. The subsequent decline in HIV seroprevalence may be due to the effect of the prevention programs that have been instituted in recent years [14]. The overall seroprevalence of HIV (3.8%) in this study is similar to the 3.8% seroprevalence in Ghana [15]. However, it is lower when compared with the 5.5% in Maiduguri [16], 10.6% in Nigeria [17] and 16.7% in Ethiopia [10]. The significantly increased HIV seropositivity among female donors compared to male donors is in accordance with the previous report [18]. This significantly increased HIV seropositivity among female donors might be due to their increased vulnerability to HIV infection as a result of biological, social and economic disadvantages related to their gender [19]. In the present study, the seropositivity rate of HIV and HBV was significantly increased among first time donors compared to repeat donors. This is in agreement with the previous studies [20-22]. The significantly increased HIV and HBV seroprevalence among first time donors might be due to the fact that people who regularly donate blood usually have a profile of low-risk of HIV and HBV infection because they were selected many times [23]. The significantly increased HIV seroprevalence among housewife donors is also consistent with previous study [24] which shows that these women acquired the infection from their partners, who commonly have sexual relations with other women without their partner's knowledge. The partner, considering her relationship to be monogamous, does not use protective methods to avoid infection. The seroprevalence of HBV (4.7%) is lower than the previous reports, 10.4% in Nigeria [25], 15.0% in Ghana [15] and 14.4% in Ethiopia [10]. The seroprevalence rate of HCV (0.7%) is in agreement with values ranging between 0 and 1.4% reported from USA and Europe [26,27] and 0.9% in Ethiopia [6]. However, it is lower than the 2.8% in Ghana [28] and the 2.9% in Port Harcourt [29]. Similarly, the seroprevalence of syphilis (1.3%) in this study is lower than the 3.6% in Maiduguri [23], 7.5% in Ghana [30], 12.8% in Ethiopia [31] and 12.7% in Tanzania [32] but is higher than the 0.1% reported in Port Harcourt [33]. The reason(s) for the relatively lower rate of seroprevalence of HBV, HCV and syphilis in this study compared with other studies cannot be discerned. The improvement in technology might make current screening reagents to be more specific and reliable; and could also be a pointer that there are geographical differences in prevalence. Significantly increased in seroprevalence of HBV was observed in the age groups of 26 - 35 and 36 - 45 years compared to the age group of greater than 45 years. This is in concurrence with previous reports by Baba et al. [16] and Ejele et al. [33] in which higher prevalence was observed among youths. This observation is worrisome since the most productive and economically viable age group of the populations is worst hit. There is the need for renewed intensification of preventive programmes aimed at high risk behavioural change. In this study, high prevalence rate of HIV, HBV, HCV and syphilis co-infections was revealed among blood donors. However, none of the donors showed the presence of three or four markers. The HIV - HBV co-infection rate of 17/50 (34%) and the 19/50 (38%) HIV - syphilis co-infection observed in this study are higher than the result in Port Harcourt[33] and lower than the 40% HIV/HBV co-infection rate reported by Lodenyo et al. [34]. This high rate of co-infection and the statistically significant relationship between HIV and syphilis, and HIV and HCV infections might be due to the fact that these pathogens share common modes of transmission and risk groups [6,16,25,35].

Conclusion

A substantial percentage of the blood donors harbour transfusion-transmissible infections, 9.5% with at least one pathogen and 0.8% with multiple infections. Transmission of transfusion-transmissible infections during the serologically negative window period still pose a threat to blood safety in environments where there is a high rate of transfusion-transmissible infection. Therefore, strict selection of blood donors with the emphasis on getting voluntary donors and comprehensive screening of donors' blood for HIV, HBV, HCV and syphilis using standard methods are highly recommended to ensure the safety of blood for recipient. The prevalence of HIV, HBV, HCV, and syphilis co-infection needs to be studied on a larger scale for the better understanding of the impact on clinical outcome and treatment response.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

BT was the primary researcher, conceived the study, designed, participated in data collection, conducted data analysis, drafted and finalized the manuscript for publication. GY, AA and AM assisted in data collection and reviewed the initial and final drafts of the manuscript. AK, FE and US interpreted the results, and reviewed the initial and final drafts of the manuscript. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2334/10/111/prepub
  22 in total

1.  The Dynamics of the AIDS Epidemic in Brazil: A Space-Time Analysis in the Period 1987-1995.

Authors: 
Journal:  Braz J Infect Dis       Date:  1998-08       Impact factor: 1.949

2.  Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia.

Authors:  Workenesh Ayele; D James Nokes; Almaz Abebe; Tsehaynesh Messele; Amare Dejene; Fikre Enquselassie; Tobias F Rinke de Wit; Arnaud L Fontanet
Journal:  J Med Virol       Date:  2002-09       Impact factor: 2.327

3.  Seroprevalence of human immunodeficiency virus among blood donors in Northwest Ethiopia, 1995-2002.

Authors:  Afework Kassu; Feleke Moges; Firew Mekonnen; Getahun Mengistu; Ebba Abate; Endris Mekonnen; Kassie Molla; Tessema Zewde; Abraham Aseffa; Yared Wondmikun; Fusao Ota
Journal:  Trop Doct       Date:  2006-04       Impact factor: 0.731

4.  Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana.

Authors:  M H Wansbrough-Jones; E Frimpong; B Cant; K Harris; M R Evans; C G Teo
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Sep-Oct       Impact factor: 2.184

5.  Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors.

Authors:  S I Rahlenbeck; G Yohannes; K Molla; R Reifen; A Assefa
Journal:  Int J STD AIDS       Date:  1997-04       Impact factor: 1.359

6.  Prevalence of blood-borne infectious diseases in blood donors in Ghana.

Authors:  William Ampofo; Nicholas Nii-Trebi; Justina Ansah; Kenji Abe; Hideo Naito; Simeon Aidoo; Victor Nuvor; James Brandful; Naoki Yamamoto; David Ofori-Adjei; Koichi Ishikawa
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Decline in prevalence of HIV-1 infection and syphilis among young women attending antenatal care clinics in Addis Ababa, Ethiopia: results from sentinel surveillance, 1995-2001.

Authors:  Aster Tsegaye; Tobias F Rinke De Wit; Yared Mekonnen; Asfaw Beyene; Mathias Aklilu; Tsehaynesh Messele; Almaz Abebe; Roel Coutinho; Eduard Sanders; Arnaud L Fontanet
Journal:  J Acquir Immune Defic Syndr       Date:  2002-07-01       Impact factor: 3.731

Review 8.  Hepatitis C.

Authors:  A I Sharara; C M Hunt; J D Hamilton
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

9.  Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.

Authors:  Christian Drosten; Thomas Nippraschk; Christoph Manegold; Helga Meisel; Veronika Brixner; W Kurt Roth; Anani Apedjinou; Stephan Günther
Journal:  J Clin Virol       Date:  2004-01       Impact factor: 3.168

10.  Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania.

Authors:  Mecky I N Matee; Pius M Magesa; Eligius F Lyamuya
Journal:  BMC Public Health       Date:  2006-01-30       Impact factor: 3.295

View more
  93 in total

1.  Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009.

Authors:  Marius Bolni Nagalo; Mahamoudou Sanou; Cyrille Bisseye; Marilène Inès Kaboré; Yacouba K Nebie; Kisito Kienou; Alice Kiba; Honorine Dahourou; Siaka Ouattara; Jean Didier Zongo; Jacques Simporé
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

Review 2.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

3.  Hepatitis B: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Barbara Bagnato; Maria Giulia Marino; Cristina Meleleo; Laura Serino; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

4.  Risk Factors for Transfusion Transmissible Infections Elicited on Post Donation Counselling in Blood Donors: Need to Strengthen Pre-donation Counselling.

Authors:  Suchet Sachdev; Kshitija Mittal; Gopal Patidar; Neelam Marwaha; Ratti Ram Sharma; Ajay Kumar Duseja; Yogesh Kumar Chawla; Sunil Kumar Arora
Journal:  Indian J Hematol Blood Transfus       Date:  2014-09-24       Impact factor: 0.900

5.  Rate of seroconversion in repeat blood donors at the national blood centre, kuala lumpur.

Authors:  A Nafishah; M Nor Asiah; A T Nur Syimah; T H Mohd Zahari; A Yasmin; M Normi; E Anza; M Shahnaz; M Y Narazah
Journal:  Indian J Hematol Blood Transfus       Date:  2012-12-21       Impact factor: 0.900

6.  Hepatitis B Virus Infection and Associated Factors Among Adults in Southwest Ethiopia: Community-Based Cross-Sectional Study.

Authors:  Alemayehu Sayih Belay; Dejene Derseh Abateneh; Sisay Shewasinad Yehualashet; Kindie Mitiku Kebede
Journal:  Int J Gen Med       Date:  2020-06-22

7.  Transfusion Transmissible Infections Among Voluntary Blood Donors at Dessie Blood Bank, Northeast Ethiopia: Cross-Sectional Study.

Authors:  Edosa Kebede; Gashaw Getnet; Getie Enyew; Daniel Gebretsadik
Journal:  Infect Drug Resist       Date:  2020-12-21       Impact factor: 4.003

8.  The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017.

Authors:  Moslem Taheri Soodejani; Ali Akbar Haghdoost; Abbas Sedaghat; Mohammad Reza Baneshi; Farzaneh Zolala
Journal:  J Blood Med       Date:  2019-12-18

9.  Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná.

Authors:  Heloise Skiavine Madeira; Claudinei Mesquita da Silva; Neila Cristina Scapini; Leyde Daiane de Peder; Jorge Juarez Vieira Teixeira
Journal:  Saudi Pharm J       Date:  2021-04-24       Impact factor: 4.330

10.  Sero-epidemiology and associated factors of HIV, HBV, HCV and syphilis among blood donors in Ethiopia: a systematic review and meta-analysis.

Authors:  Mulugeta Melku; Sintayehu Ambachew; Bamlaku Enawgaw; Molla Abebe; Zegeye Abebe; Tekalign Deressa; Debasu Damtie; Belete Biadgo; Belay Tessema; Demeke Geremew; Asemarie Kebede; Berhanu Woldu; Takele Teklu; Elias Shiferaw
Journal:  BMC Infect Dis       Date:  2021-08-09       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.